Split-Face Comparison of Ultrapulse-Mode and Superpulse- Mode Fractionated Carbon Dioxide Lasers on Photoaged Skin
November 2012 | Volume 11 | Issue 11 | 1310 | Copyright © November 2012
Yao-Jia Luo MD,a Xue-Gang Xu MD,a Yan Wu PhD,a Tian-Hua Xu PhD,a John Z. S. Chen PhD,b Xing-Hua Gao PhD,a Hong-Duo Chen MD,a and Yuan-Hong Li PhDa
aDepartment of Dermatology, No.1 Hospital of China Medical University, Shenyang, Liaoning, China bSheftel Associates Dermatology, Tucson, AZ
Abstract
Background: Both ultrapulse-mode and superpulse-mode fractional CO2 lasers (UPCO2 and SPCO2) could be successfully used
in treating photoaged skin.
Objective: This evidence-based study was intended to compare the therapeutic and adverse effects of UPCO2 and SPCO2 in treating
photoaged skin in Chinese subjects.
Methods: Eighteen Chinese subjects with Fitzpatrick skin type IV were enrolled in a randomized, split-face trial. Subjects received
SPCO2 on one half of the face and UPCO2 on the other half. Before and after photos, skin color, epidermal water content,
sebum level, periorbital wrinkles, skin roughness, and self-esteem questionnaires were used.
Results: Global evaluation and subjects' self-esteem assessments showed a similar trend at 1-month and 3-month follow-up visits
on both sides. The UPCO2 laser has a shorter downtime of 6.25±2.71 days compared with 6.41±2.67 days for SPCO2, but has
a higher incidence of edema, spot bleeding, prolonged redness and postinflammatory hyperpigmentation. More subjects prefer
SPCO2 treatment because of similar efficacy and fewer adverse effects.
Conclusion: The effectiveness of the SPCO2 laser in treating photoaged skin is very similar to the UPCO2 laser, with less erythema,
but more crusting and longer downtime.
J Drugs Dermatol. 2012;11(11):1310-1314
INTRODUCTION
Ablative skin resurfacing (ASR) provides significant improvement
in reversing signs of cutaneous photoaged
skin1-6 but is limited by adverse postoperative sequelae
such as extended recovery times, risk of infection, scarring,
and persistent pigmentary changes.7,8 In contrast to ASR, which
aims to achieve homogeneous thermal damage at a particular
depth within the skin,9 ablative fractional photothermolysis
produces arrays of microscopic thermal zones, creating small
columns of thermal injury without injuring surrounding tissue.
10 This fractionated skin injury leaves small bridges of normal
skin intact, which is thought to act as a natural bandage
promoting reepithelialization within less than 48 hours with no
loss of epithermal barrier function.1,11-13
Ultrapulse-mode fractional carbon dioxide (UPCO2) and superpulse-
mode fractional carbon dioxide (SPCO2) are 2 commonly
used modes in treating photoaged skin. Theoretically, UPCO2 delivers
a "flat-top" pulse beam, with a higher fluence and shorter
pulse duration, while SPCO2 delivers a stack of superpulse-shaped
beams, which at the beginning of the pulse, produce a burst of energy
that tails off throughout the duration of the pulse.14 Although
the peak fluence of SPCO2 is only one third of UPCO2, the pulse
duration is 3 times longer. It is postulated that the longer dwelling
time compensates for the insufficiency of the pulse energy so
that epidermal ablation can occur. We designed a split-face study
to compare the efficacy and side effects of UPCO2 and SPCO2 in
treating photoaged skin in Chinese subjects.
PATIENTS AND METHODS
Subjects
Eighteen female Chinese subjects (mean ± standard deviation
age, 50±5.03 years; Fitzpatrick skin type IV) with obvious
photoaged skin manifested as fine rhytids, irregular pigmentation,
wrinkles, and skin laxity were enrolled from November
2009 to February 2010.15 The exclusion criteria were patients
with concomitant treatments, pregnancy, skin cancer, a history
of keloid, vitiligo, recurrent facial herpes simplex infection,
diabetes, coagulation malfunction, infectious lesions, recent
extensive sun exposure, and oral administration of photosensitive
drugs.16 The study was approved by the Medical Ethics and
Human Research Committee of China Medical University. All
patients were informed of the risks, benefits, and possible complications
of the treatment before enrollment into the study.
Informed consent was obtained from each patient.
Equipment
The UPCO2 treatment was performed with the DeepFXTM handpiece
of the UltraPulse CO2 fractionated laser (Lumenis Inc,